A.G. Schneiderman Announces $22.4 Million Settlement With NYC Pharmacy For Improper Medicaid Billings For Injectable Pediatric Drug Synagis
NEW YORK - Attorney General Eric T. Schneiderman today announced a settlement that returns $22.4 million to the state's Medicaid program. The agreement reached with the pharmacy Trinity Homecare LLC, primarily owned by Walgreen Co., began with a whistleblower claim of improper conduct and false Medicaid billings by the company and led to an expanded investigation by the Attorney General. The settlement relates to Synagis, an injectable drug for certain at-risk premature infants. The drug can cost more than $2,000 per dose, with some babies requiring additional vials based on their weight. The settlement resolve claims of improper prescriptions and billings for patients in New York City, Dutchess, Orange, Rockland, Sullivan, Westchester and Ulster counties, and on Long Island, and allegations that Trinity lacked basic documentation for Medicaid claims it submitted or proof it delivered Synagis.
- Date:July 10, 2015
- Agency:New York Attorney General
- State Enforcement Agencies